Ondansetron Injection
Product Images NDC 0143-9890

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 0143-9890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by West-ward Pharmaceuticals Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ondansetron Injection 1)

Structural Formula (Ondansetron Injection 1)
Chemical structure diagram of Ondansetron, showing its molecular composition including rings and functional groups, labeled with its hydrochloride dihydrate form (HCl•2H₂O).*
FDA Label Image

Ndc 0143-9891-01 Ondansetron Injection, Usp 4 mg/2 mL (2 mg/ml) Sterile For Iv Or Im Use Rx Only 2 mL Single Dose Vial Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Ondansetron Injection 2)

Ndc 0143-9891-01 Ondansetron Injection, Usp 4 mg/2 mL (2 mg/ml) Sterile For Iv Or Im Use Rx Only 2 mL Single Dose Vial Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Ondansetron Injection 2)
Ondansetron Injection USP label for 4 mg/2 mL (2 mg/mL) sterile injection vial, indicated for intravenous or intramuscular use. The label includes dosage form and strength, storage instructions, manufacturer and distributor information from West-Ward Pharmaceuticals Corp, and space for lot and expiration dates. The label design features a white and blue color scheme with black and yellow accents.*
FDA Label Image

Ndc 0143-9890-01 Ondansetron Injection, Usp 40 mg/20 mL (2 mg/ml) Sterile For Iv Or Im Use Rx Only 20 mL Multiple Dose Vial Each 1 mL Of Aqueous Solution In The 20 mL Multidose Vial Contains 2 mg Of Ondansetron As The Hydrochloride Dihydrate; 8.3 mg Of Sodium Chloride, Usp; 0.5 mg Of Citric Acid Monohydrate, Usp And 0.25 mg Trisodium Citrate Dihydrate, Usp As Buffers; And 1.2 mg Of Methylparaben, Nf And 0.15 mg Of Propylparaben As Preservatives In Water For Injection, Usp. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Ondansetron Injection 3)

Ndc 0143-9890-01 Ondansetron Injection, Usp 40 mg/20 mL (2 mg/ml) Sterile For Iv Or Im Use Rx Only 20 mL Multiple Dose Vial Each 1 mL Of Aqueous Solution In The 20 mL Multidose Vial Contains 2 mg Of Ondansetron As The Hydrochloride Dihydrate; 8.3 mg Of Sodium Chloride, Usp; 0.5 mg Of Citric Acid Monohydrate, Usp And 0.25 mg Trisodium Citrate Dihydrate, Usp As Buffers; And 1.2 mg Of Methylparaben, Nf And 0.15 mg Of Propylparaben As Preservatives In Water For Injection, Usp. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Ondansetron Injection 3)
Ondansetron Injection, USP 40 mg/20 mL (2 mg/mL) sterile solution multiple dose vial label. The label states use for intravenous (IV) or intramuscular (IM) administration, Rx only. It includes storage instructions and a list of inactive ingredients. The labeler is West-Ward Pharmaceutical Corp with manufacturer HIKMA Farmacêutica (Portugal).*
FDA Label Image

Ndc 0143-9890-10 Rx Only Ondansetron Injection, Usp 40 mg/20 mL (2 mg/ml) Sterile For Iv Or Im Administration 10 X 20 mL Multiple Dose Vials Each 1 mL Of Aqueous Solution In The 20 mL Multiple Dose Vial Contains 2 mg Of Ondansetron As The Hydrochloride Dihydrate; 8.3 mg Sodium Chloride, Usp; 0.5 mg Of Citric Acid Monohydrate, Usp And 0.25 mg Trisodium Citrate Dihydrate, Usp As Buffers; And 1.2 mg Of Methylparaben, Nf And 0.15 mg Of Propylparaben As Preservatives In Water For Injection, Usp. Usual Dosage: See Package Insert. Store Between 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Ondansetron Injection 4)

Ndc 0143-9890-10 Rx Only Ondansetron Injection, Usp 40 mg/20 mL (2 mg/ml) Sterile For Iv Or Im Administration 10 X 20 mL Multiple Dose Vials Each 1 mL Of Aqueous Solution In The 20 mL Multiple Dose Vial Contains 2 mg Of Ondansetron As The Hydrochloride Dihydrate; 8.3 mg Sodium Chloride, Usp; 0.5 mg Of Citric Acid Monohydrate, Usp And 0.25 mg Trisodium Citrate Dihydrate, Usp As Buffers; And 1.2 mg Of Methylparaben, Nf And 0.15 mg Of Propylparaben As Preservatives In Water For Injection, Usp. Usual Dosage: See Package Insert. Store Between 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Ondansetron Injection 4)
Ondansetron Injection, USP 40 mg/20 mL (2 mg/mL) sterile solution for intravenous or intramuscular administration. The label indicates 10 vials of 20 mL multiple-dose injections. Distributed by West-Ward Pharmaceuticals Corp, Eatontown, NJ. Includes dosage strength and storage instructions.*
FDA Label Image

Ondansetron Injection 5

Ondansetron Injection 5
A label displaying product identification details for Ondansetron injection 2 mg/mL by West-Ward Pharmaceuticals Corp. The label includes a QR code, GTIN, serial number, expiration date, and lot number information in a black and white layout.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.